Target phosphate and calcium levels in patients undergoing hemodialysis: a post-hoc analysis of the LANDMARK study.

Kiryu YoshidaTakuya MizukamiMasafumi FukagawaTadao AkizawaHokuto MorohoshiTakehiko SambeHidetoshi ItoHiroaki OgataNaoki Uchidanull null

Published in: Clinical and experimental nephrology (2022)

Managing albumin-adjusted Ca < 9.1 mg/dL may reduce the cardiovascular risk among patients undergoing hemodialysis. Hypophosphatemia < 3.6 mg/dL may be associated with mortality.

Keyphrases

patients undergoing
peritoneal dialysis
end stage renal disease
chronic kidney disease
cardiovascular events
risk factors
cardiovascular disease